Literature DB >> 3497655

Cytotoxic factors secreted by cells infected by human immunodeficiency virus type I.

L Ratner, S H Polmar, N Paul, N Ruddle.   

Abstract

Conditioned media from human immunodeficiency virus type I (HIV-1) infected cells were tested for cytotoxic cell-derived factors. The assay used a murine fibroblast cell line which is sensitive to the effects of tumor necrosis factors, but nonpermissive for HIV-1 replication. Cytotoxic activity was detected in cultures of peripheral blood mononuclear cells infected with HIV-1. However, no differences in activity were found in conditioned media from infected lymphoid or monocytoid cell lines compared to their uninfected counterparts. These data suggest that cytotoxic activities of this type are not mediators of cell killing resulting from HIV-1 infection. Thus, this cytotoxic activity is a direct or indirect result of virus replication or cytopathicity. One should consider a role for this cytotoxic factor, secreted by HIV-1 infected mononuclear cells, in various aspects of infection in vivo, such as AIDS encephalopathy or the systemic manifestations accompanying ARC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497655     DOI: 10.1089/aid.1987.3.147

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  Colocalisation of human immunodeficiency virus and human cytomegalovirus infection in brain autopsy tissue from AIDS patients.

Authors:  I M Balluz; M A Farrell; E Kay; M J Staunton; J N Keating; O Sheils; S L Cosby; M J Mabruk; B J Sheahan; G J Atkins
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

Review 2.  Is TNF involved in the progression of AIDS?

Authors:  N Kobayashi; Y Hamamoto; N Yamamoto
Journal:  Virus Genes       Date:  1990-07       Impact factor: 2.332

3.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

Authors:  T Matsuyama; Y Hamamoto; G Soma; D Mizuno; N Yamamoto; N Kobayashi
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.

Authors:  P Portegies; J de Gans; J M Lange; M M Derix; H Speelman; M Bakker; S A Danner; J Goudsmit
Journal:  BMJ       Date:  1989-09-30

5.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.

Authors:  L Buonaguro; G Barillari; H K Chang; C A Bohan; V Kao; R Morgan; R C Gallo; B Ensoli
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  AIDS dementia complex complicated by cytomegalovirus encephalopathy.

Authors:  M Fiala; E J Singer; M C Graves; W W Tourtellotte; J A Stewart; C A Schable; R H Rhodes; H V Vinters
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

7.  Lymphotoxin activation by human T-cell leukemia virus type I-infected cell lines: role for NF-kappa B.

Authors:  N L Paul; M J Lenardo; K D Novak; T Sarr; W L Tang; N H Ruddle
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter.

Authors:  D K Biswas; T R Salas; F Wang; C M Ahlers; B J Dezube; A B Pardee
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.

Authors:  N H Ruddle; C M Bergman; K M McGrath; E G Lingenheld; M L Grunnet; S J Padula; R B Clark
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.